Increased levels of C-reactive protein in noncontrolled type II diabetic subjects.

[1]  I. Macdougall,et al.  Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. , 1997, Clinical nephrology.

[2]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[3]  B. Keagy,et al.  An acute phase reaction in diabetic patients with foot ulcers. , 1997, Cardiovascular surgery.

[4]  H. Becher,et al.  The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. , 1996, Thrombosis research.

[5]  P. Rossing,et al.  Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. , 1996, Thrombosis research.

[6]  S. Amemiya,et al.  Antioxidants in the serum of children with insulin-dependent diabetes mellitus. , 1993, Free radical biology & medicine.

[7]  Pearson Jd,et al.  Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein. , 1991 .

[8]  B. Leaker,et al.  Haemostatic activation and proteinuria as factors in the progression of chronic renal failure. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  D E McMillan,et al.  Increased levels of acute-phase serum proteins in diabetes. , 1989, Metabolism: clinical and experimental.

[10]  R. Mueller,et al.  On the Therapy of Disturbances of Blood Fluidity , 1985, Angiology.

[11]  M. De.  Plasma protein changes, blood viscosity, and diabetic microangiopathy. , 1976 .